XTANT MEDICAL HOLDINGS, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 5.08 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-09-30 was 5.25M shares.
- XTANT MEDICAL HOLDINGS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-06-30 was 5.25M shares.
- XTANT MEDICAL HOLDINGS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2023-09-30 was 5.25B shares.
- XTANT MEDICAL HOLDINGS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-06-30 was 1.99M shares.
- XTANT MEDICAL HOLDINGS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2025 was 5.08M shares.
- XTANT MEDICAL HOLDINGS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 5.25B shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | 5.08M shares 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 5.25M shares 10-Q · filed 2025-11-10 | 5.25M shares 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | 5.25M shares 10-Q · filed 2026-08-11 | 5.25M shares 10-Q · filed 2026-08-11 | ||
| 2023-12-31 | 5.25B shares 10-K · filed 2025-03-06 | |||
| 2023-09-30 | 5.25B shares 10-Q · filed 2024-11-12 | 5.25B shares 10-Q · filed 2024-11-12 | ||
| 2012-06-30 | 1.99M shares 10-Q · filed 2012-08-10 | |||
| 2011-09-30 | 4.83M shares 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | 5.80M shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |